Abstract:Dendrimers are synthetic macromolecules with a highly-branched structure and high concentration of surface groups. Among dendrimers, Poly(amidoamine) (PAMAM) has received substantial attention as a novel drug carrier and delivery system. Depending on the generation and type of terminal groups, dendrimer toxicity could change and include cytotoxicity. Although PAMAM is water soluble, molecular modeling of the dendrimer-drug complex is considered challenging for exploring the conformational mobility of dendrimers and atomic specific interactions during the dendrimer-drug association. However, conventional protocols for predicting binding affinities have been designed for small protein molecules or protein-protein complexes that can be applied to study the dendrimer-drug association. In this work, we performed docking calculations for a set of 94 previously reported compounds on PAMAM of fourth generation (G4-PAMAM) to select six compounds, cromoglicic acid (CRO) - a mast cell stabilizer, Fusidic acid (FUS) - a bacteriostatic antibiotic, and Methotrexate (MTX) - a chemotherapy agent and immune system suppressant, which have the highest affinities for G4-PAMAM, and Lidocaine (LDC) - used to numb tissue in a specific area and for ventricular tachycardia treatment, Metoprolol (MET) - a β1 receptor blocker, and Pindolol (PIN) - a β blocker, which have the lowest affinities for the G4-PAMAM dendrimer, to perform MD simulations combined with the molecular mechanics generalized/Poisson-Boltzmann surface area MMGBSA/MMPBSA approach to investigate the interactions of generating 4 charge-neutral, charge-basic and charge-acid G4-PAMAM dendrimers. In addition, to validate these theoretical G4-PAMAM-drug complexes, the complexes were experimentally conjugated to determine their stability in aqueous solubility studies immediately and over one year. Our results show that among the different commercial drugs, both charged and neutral PAMAM have the most favorable binding free energies for CRO, MTX, and FUS, which appears to be due to a complex counterbalance of electrostatics and van der Waals interactions. These theoretical and aqueous solubility studies supported the high affinity of methotrexate for the G4-PAMAM-drug due to its carboxyl and aryl moieties that favor its accommodation by noncovalent interactions.

Synthesis, characterization and evaluation of pegylated-citric acid based dendrimers as drug delivery agents

Lysine and citric acid based pegylated polymeric dendritic nano drug delivery carrier and their bioactivity evaluation

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Synthesis of Degradable Bifunctional Dendritic Polymers As Versatile Drug Carriers

Synthesis and Evaluation of a Nanoglobular Dendrimer 5-Aminosalicylic Acid Conjugate with a Hydrolyzable Schiff Base Spacer for Treating Retinal Degeneration

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.

PEGylated PAMAM Dendrimers As a Potential Drug Delivery Carrier:In Vitroandin Vivocomparative Evaluation of Covalently Conjugated Drug and Noncovalent Drug Inclusion Complex

Dendrimers As Drug Carriers: Applications in Different Routes of Drug Administration

Synthesis of PEGylated PAMAM Dendrimer As a Drug Carrier

Dendrimer-Based Prodrugs: Design, Synthesis, Screening And Biological Evaluation

Synthesis, dynamics and applications (cytotoxicity and biocompatibility) of dendrimers: a mini-review

Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa

Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers

Peptide- and Saccharide-Conjugated Dendrimers for Targeted Drug Delivery: a Concise Review.

PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding

Stimuli-Responsive Dendrimers as Nanoscale Vectors in Drug and Gene Delivery Systems: A Review Study

Lauryl alcohol functionalized citric acid-based dendrimers as the drug carrier for in vitro evaluation

DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE

PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance

Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions

A Non-Cytotoxic Dendrimer with Innate and Potent Anticancer and Anti-Metastatic Activities